about
sameAs
Bacteriophage Procurement for Therapeutic PurposesPhage neutralization by sera of patients receiving phage therapyPhage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes.Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy.Bacteriophages in the gastrointestinal tract and their implicationsPhages and immunomodulation.Antiphage activity of sera during phage therapy in relation to its outcome.Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.Corrigendum: Bacteriophage Procurement for Therapeutic Purposes.Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes.Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro.Potential possibilities of using phage typing in elimination of multidrug resistant staphylococci.The Potential of Phage Therapy in Sepsis.Preparation of endotoxin-free bacteriophages.Phage therapy in allergic disorders?Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy.[The presence of bacteriophages in human feces and their potential importance].Phage Therapy: Beyond Antibacterial Action.Phage Therapy: What Have We Learned?Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferationBacteriophages and Lysins in Biofilm ControlPhage Therapy in Prostatitis: Recent Prospects
P50
Q26738479-DE330957-E604-40FF-AB97-6F3FA35004A5Q33828266-386986F7-9A8B-4AA9-A903-05330EA59F2DQ33850107-FA9A57C5-6A6C-40D6-BB1C-0544BA0AB53CQ36400914-5B77290C-73B9-4922-8D3D-CB184DC0C832Q37360042-09D572EA-CE06-4F41-9D73-0DDFCFDB968CQ38622847-7E7BDB58-B4BF-4545-A950-ACEADD8A009BQ38691927-275641D1-E42B-4814-BC0B-0C6FB6213342Q38819873-8D95F0C1-A724-423E-889E-69E310BE268FQ39696206-421B71E6-CA9C-4C2D-90E0-026EEE49881AQ42371696-3B4040D8-D0FA-4DB0-96D0-DC1AF5F93463Q43468019-C0100F57-F558-43A9-9A1F-C4F0DFF0DD75Q44356634-41F7AAD7-9B1A-418E-ABB3-23BD38B7F297Q46738858-1EF9F6F2-6940-49CA-837E-EFD318328315Q47194133-B593FEAE-4EAD-4715-B164-B899F7F6CC08Q47300414-2DE59946-6C59-43DE-B236-0CF925F53E2AQ47550004-52DCD7AF-F37A-4D3B-9B04-6D424EA83DE5Q49507986-A9CA3EB8-CAAD-46C5-831A-B1BFB430658BQ50074481-EF9C2909-0FDE-400E-B45B-1E36B3A8229EQ55299223-3B34814D-7693-4487-A341-ABCE97F64653Q59360291-CAA44F0F-B73B-4A5B-BEBC-4CA8708B9316Q73886704-471A559B-224A-42DA-9513-E893B93D65A9Q89993494-F28F01BC-AD04-43CD-A5B5-81A6528E1243Q90220010-0060A713-89C4-4878-B0A5-80A4B914C599
P50
description
researcher
@en
name
Marzanna Łusiak-Szelachowska
@en
Marzanna Łusiak-Szelachowska
@nl
type
label
Marzanna Łusiak-Szelachowska
@en
Marzanna Łusiak-Szelachowska
@nl
altLabel
Lusiak-Szelachowska M
@en
Lusiak-Szelachowska M.
@en
Lusiak-Szelachowska
@en
M Lusiak-Szelachowska
@en
M Łusiak-Szelachowska
@en
M. Lusiak-Szelachowska
@en
M. Łusiak-Szelachowska
@en
Marzanna Lusiak-Szelachowska
@en
Łusiak-Szelachowska M
@en
Łusiak-Szelachowska M.
@en
prefLabel
Marzanna Łusiak-Szelachowska
@en
Marzanna Łusiak-Szelachowska
@nl
P31
P496
0000-0001-8535-258X